Literature DB >> 25792631

Influenza virus-induced lung injury: pathogenesis and implications for treatment.

Susanne Herold1, Christin Becker2, Karen M Ridge3, G R Scott Budinger3.   

Abstract

The influenza viruses are some of the most important human pathogens, causing substantial seasonal and pandemic morbidity and mortality. In humans, infection of the lower respiratory tract of can result in flooding of the alveolar compartment, development of acute respiratory distress syndrome and death from respiratory failure. Influenza-mediated damage of the airway, alveolar epithelium and alveolar endothelium results from a combination of: 1) intrinsic viral pathogenicity, attributable to its tropism for host airway and alveolar epithelial cells; and 2) a robust host innate immune response, which, while contributing to viral clearance, can worsen the severity of lung injury. In this review, we summarise the molecular events at the virus-host interface during influenza virus infection, highlighting some of the important cellular responses. We discuss immune-mediated viral clearance, the mechanisms promoting or perpetuating lung injury, lung regeneration after influenza-induced injury, and recent advances in influenza prevention and therapy.
Copyright ©ERS 2015.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25792631     DOI: 10.1183/09031936.00186214

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  141 in total

1.  Inhibiting Bruton's tyrosine kinase rescues mice from lethal influenza-induced acute lung injury.

Authors:  Jon M Florence; Agnieszka Krupa; Laela M Booshehri; Sandra A Davis; Michael A Matthay; Anna K Kurdowska
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-03-08       Impact factor: 5.464

2.  Matrix metalloproteinase-9 deficiency protects mice from severe influenza A viral infection.

Authors:  Joselyn Rojas-Quintero; Xiaoyun Wang; Jennifer Tipper; Patrick R Burkett; Joaquin Zuñiga; Amit R Ashtekar; Francesca Polverino; Amit Rout; Ilyas Yambayev; Carmen Hernández; Luis Jimenez; Gustavo Ramírez; Kevin S Harrod; Caroline A Owen
Journal:  JCI Insight       Date:  2018-12-20

3.  Bronchioalveolar stem cells are a main source for regeneration of distal lung epithelia in vivo.

Authors:  Isabelle Salwig; Birgit Spitznagel; Ana Ivonne Vazquez-Armendariz; Keynoosh Khalooghi; Stefan Guenther; Susanne Herold; Marten Szibor; Thomas Braun
Journal:  EMBO J       Date:  2019-04-26       Impact factor: 11.598

4.  Understanding the role of host response in influenza pneumonitis.

Authors:  Benjamin M Tang; Carl G Feng; Anthony S McLean
Journal:  Intensive Care Med       Date:  2019-04-24       Impact factor: 17.440

5.  An Official American Thoracic Society Workshop Report 2015. Stem Cells and Cell Therapies in Lung Biology and Diseases.

Authors:  Darcy E Wagner; Wellington V Cardoso; Sarah E Gilpin; Susan Majka; Harald Ott; Scott H Randell; Bernard Thébaud; Thomas Waddell; Daniel J Weiss
Journal:  Ann Am Thorac Soc       Date:  2016-08

Review 6.  Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.

Authors:  David S Fedson
Journal:  Ann Transl Med       Date:  2016-11

Review 7.  [Influenza].

Authors:  C Malainou; S Herold
Journal:  Internist (Berl)       Date:  2019-11       Impact factor: 0.743

8.  Constitutively Expressed IFITM3 Protein in Human Endothelial Cells Poses an Early Infection Block to Human Influenza Viruses.

Authors:  Xiangjie Sun; Hui Zeng; Amrita Kumar; Jessica A Belser; Taronna R Maines; Terrence M Tumpey
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

9.  Defining the role of pulmonary endothelial cell heterogeneity in the response to acute lung injury.

Authors:  Terren K Niethamer; Collin T Stabler; John P Leach; Jarod A Zepp; Michael P Morley; Apoorva Babu; Su Zhou; Edward E Morrisey
Journal:  Elife       Date:  2020-02-24       Impact factor: 8.140

10.  Human Alveolar Macrophages May Not Be Susceptible to Direct Infection by a Human Influenza Virus.

Authors:  David B Ettensohn; Mark W Frampton; Joan E Nichols; Norbert J Roberts
Journal:  J Infect Dis       Date:  2016-09-06       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.